MarginsXMarginsX
Home › Markets › Health Care › QUCY

Quantum Cyber N.V. (QUCY)

QUCY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5850
-7.58% on the day
Market cap
$51.0M
Micro cap
Revenue · 2025
$537K
-39.9% on 2024
Net income · 2025
-$16.2M
-3018.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1874252/000121390026037676/0001213900-26-037676-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerQUCY on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryGermany
IPO year2021
SEC CIK0001874252
SEC industry codePharmaceutical Preparations
Incorporated inNetherlands

Financials · 2025

LineValue
Revenue$537K
Net income-$16.2M
Operating income-$16.1M
Net margin-3018.3%
Operating margin-3005.0%
Revenue growth-39.9%
Cash$889K
Total assets$5.3M
P/E (computed)Net income was not positive
P/S (computed)95.0×

Warning signs

Cash runway
3.7 months
$4.9M cash at September 30, 2026
Share count, 1 year
No year-earlier count
+312.2% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raised substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued."
10-Q 2026-11-12
Cash and burn$4.9M cash; operating cash flow -$4.0M a quarter.Report 2026-09-30
Shares outstanding87,241,735 (2026-11-12); 21,165,482 three years earlier.Cover page 2026-11-12
Reverse splits, 3 years1; latest on 2026-04-28Source 2026-04-28
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 4 424B5 takedowns, 3 at the marketLatest 2026-10-09
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-03-25
AuditorReliant CPA PC, Newport Beach, California, United States; changed auditors 1 time in 24 months8-K 4.01 2026-06-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$967K-$5.4M-$4.3M$4.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$11.0M-$7.2M$13.4M$169KNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$5.1M-$2.7M$4.7M$127KNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$4.8M-$1.7M$889K$2.2M$537K10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$2.9M-$2.6M$1.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$3.5M-$2.7M$1.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$5.0M-$3.9M$1.7MNo debt tagsNeeds four quarters10-Q 2026-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-10-09
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-11-13
Latest proxy
DEFINITIVE PROXY STATEMENT
DEF 14A2026-06-01

Source: SEC EDGAR submissions feed, 207 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.3%
1 month-43.5%
3 months-55.4%
Year to date-43.5%
1 year-56.6%
From 52-week high-82.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RFLRafael Holdings Inc.$0.9701-9.34%$50.6M
SDEVStablecoin Development Corporation$0.7055-9.55%$51.6M
APLMApollomics Inc.$17.84+0.91%$51.7M
IBIOiBio Inc.$0.7067-3.42%$49.8M
CTORCitius Oncology Inc.$0.5350-6.76%$49.7M
CLNNClene Inc.$3.66-6.63%$52.7M
MREOMereo BioPharma Group plc$0.3050-0.81%$48.7M
HOWLWerewolf Therapeutics Inc.$0.9908+1.07%$48.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier